LONG-TERM OUTCOMES IN BREAST CANCER PATIENTS AFTER COMPLEX TREATMENT WITH ADJUVANT RADIATION THERAPY

by K. A. Simonov, Zh. A. Startseva, E. M. Slonimskaya
Published 2016-02-01

RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS

by K. A. Simonov, Zh. A. Startseva, E. M. Slonimskaya
Published 2016-02-01

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER

by E. M. Slonimskaya, N. A. Tarabanovskaya, A. V. Doroshenko, S. V. Patalyak
Published 2016-07-01

Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor

by M. K. Ibragimova, M. M. Tsyganov, E. M. Slonimskaya, N. V. Litviakov
Published 2020-10-01

The influence of functional skewness on prognosis of cancer of mammary gland

by L. E. Erendeeva, M. V. Zavyalova, E. M. Slonimskaya, V. M. Perelmuter
Published 2002-03-01

Chymotrypsin-like and caspase-like proteasome activities in breast cancer

by E. E. Shashova, I. V. Kondakova, E. M. Slonimskaya, S. A. Glushenko, E. S. Kolegova
Published 2016-02-01

Prognosis method to predict small-sized breast cancer affected by fibrocystic disease

by S. A. Velichko, E. M. Slonimskaya, I. G. Frolova, D. G. Bukharin, A. V. Doroshenko
Published 2017-04-01

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer

by E. M. Slonimskaya, A. V. Doroshenko, P. V. Kazantseva, N. A. Tarabanovskaya, R. Yu. Vernadsky
Published 2018-10-01

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer

by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. A. Usynin, E. M. Slonimskaya
Published 2019-04-01

IMPACT OF TRANSCRIPTION FACTORS, VEGF AND PROTEASES ON KIDNEY CANCER PROGRESSION

by L. V. Spirina, I. V. Kondakova, E. A. Usynin, E. M. Slonimskaya, Z. A. Yurmazov
Published 2018-09-01

TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION

by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. M. Slonimskaya, E. A. Usynin
Published 2018-03-01

PROTEASOMAL AND CALPAIN PROTEOLYSIS SYSTEMS IN DIFFERENT MOLECULAR SUBTYPES OF BREAST CANCER

by E. E. Shashova, A. V. Doroshenko, L. N. Bondar, E. M. Slonimskaya, I. V. Kondakova
Published 2017-07-01

ROLE OF NEUREGULINS AND HEPATOCYTE GROWTH FACTOR IN THE DEVELOPMENT OF CASTRATION-RESISTANT PROSTATE CANCER

by L. V. Spirina, E. A. Usynin, E. M. Slonimskaya, I. V. Kondakova, A. K. Gorbunov
Published 2016-02-01

EXPRESSION OF TRANSCRIPTION FACTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR AND ACTIVITY OF INTRACELLULAR PROTEASES IN LOCALIZED AND DISSEMINATED KIDNEY CANCERS

by L. V. Spirina, Ye. A. Usynin, I. V. Kondakova, Z. A. Yurmazov, E. M. Slonimskaya
Published 2016-02-01

SINGLE NUCLEOTIDE POLYMORPHISMS IN BREAST TUMOR AND EXPRESSION OF ABC-TRANSPORTERS AFTER NEOADJUVANT CHEMOTHERAPY

by M. M. Tsyganov, M. K. Ibragimova, E. M. Slonimskaya, N. V. Cherdyntseva, N. V. Litviakov
Published 2016-02-01

ANALYSIS OF ASSOCIATIONS OF VEGF-A GENE POLYMORPHISM AT POSITIONS 2578A/C AND +936C/T WITH DIFFERENT RECEPTOR STATUS IN BREAST CANCER PATIENTS

by A. V. Shevchenko, V. I. Konenkov, N. N. Babyshkina, O. V. Savenkova, E. M. Slonimskaya
Published 2016-02-01

Sonography and mammogram in the diagnosis of mammary cancer developed because of the non-malignant proliferative changes

by M. A. Tsesarsky, I. G. Frolova, D. G. Bukharin, N. Yu. Fomina, E. M. Slonimskaya, S. A. Velichko
Published 2002-06-01

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

by N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Published 2020-04-01

CHARACTERISTICS OF BILATERAL BREAST CANCER HEMATOGENOUS METASTASIS

by E. A. Fesik, N. V. Krakhmal, M. V. Zavyalova, E. M. Slonimskaya, S. V. Vtoryshin, V. M. Perelmuter
Published 2016-02-01

Predictive Significance of Vascular Endothelial Growth Factor receptor VEGF-2 in triple-negative breast cancer patients

by N. N. Babyshkina, M. V. Zavyalova, O. D. Bragina, T. A. Dronova, E. M. Slonimskaya, N. V. Cherdyntseva
Published 2016-11-01